InvestorsHub Logo
Followers 10
Posts 1479
Boards Moderated 0
Alias Born 12/15/2013

Re: hemopure36 post# 22956

Friday, 05/22/2020 6:59:31 AM

Friday, May 22, 2020 6:59:31 AM

Post# of 27413
I thought he did fine with the interview except for the virus part. Cavuto clearly opens the door for him to tout what it does for CV19. That was the specific question. Dr. C was so intent on completing his "revenues rose by 78%"script that Cavuto cut him off on (because he wanted to hear about the virus treatment) I think he muffed this portion. He had the opportunity to really play it up. Also, if I dont know about us and the CEO is talking about 100 treatments it doesnt do much for me. I'd be leaving the small number out. Just my opinion. Shifting, I thought the blood thinner removal went very well and Cavuto "gets it" with his comments about bleeding. Just thought he could have done better on the virus.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CTSO News